Lung-Gut Microbiota and Tryptophan Metabolites Changes in Neonatal Acute Respiratory Distress Syndrome

References

• Chi M, Mei YB, Feng ZC. A review on neonatal acute respiratory distress syndrome. Zhongguo Dang Dai Er Ke Za Zhi. 2018;20(9):724–728. doi:10.7499/j.issn.1008-8830.2018.09.006
   PubMedGoogle Scholar
• De Luca D, Tingay DG, van Kaam AH, et al. Epidemiology of neonatal acute respiratory distress syndrome: prospective, multicenter, international cohort study. Pediatr Crit Care Med. 2022;23(7):524–534. doi:10.1097/PCC.0000000000002961
   PubMed Web of Science ®Google Scholar
• Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat Rev Immunol. 2016;16(6):341–352. doi:10.1038/nri.2016.42
   PubMed Web of Science ®Google Scholar
• Cryan JF, O’Riordan KJ, Cowan C, et al. The microbiota-gut-brain axis. Physiol Rev. 2019;99(4):1877–2013. doi:10.1152/physrev.00018.2018
   PubMed Web of Science ®Google Scholar
• Agus A, Planchais J, Sokol H. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe. 2018;23(6):716–724. doi:10.1016/j.chom.2018.05.003
   PubMed Web of Science ®Google Scholar
• Budden KF, Gellatly SL, Wood DL, et al. Emerging pathogenic links between microbiota and the gut-lung axis. Nat Rev Microbiol. 2017;15(1):55–63. doi:10.1038/nrmicro.2016.142
   PubMed Web of Science ®Google Scholar
• Wypych TP, Wickramasinghe LC, Marsland BJ. The influence of the microbiome on respiratory health. Nat Immunol. 2019;20(10):1279–1290. doi:10.1038/s41590-019-0451-9
   PubMed Web of Science ®Google Scholar
• Natalini JG, Singh S, Segal LN. The dynamic lung microbiome in health and disease. Nat Rev Microbiol. 2023;21(4):222–235. doi:10.1038/s41579-022-00821-x
   PubMed Web of Science ®Google Scholar
• Budden KF, Shukla SD, Rehman SF, et al. Functional effects of the microbiota in chronic respiratory disease. Lancet Respir Med. 2019;7(10):907–920. doi:10.1016/S2213-2600(18)30510-1
   PubMed Web of Science ®Google Scholar
• Freestone PP, Hirst RA, Sandrini SM, et al. Pseudomonas aeruginosa-catecholamine inotrope interactions: a contributory factor in the development of ventilator-associated pneumonia? Chest. 2012;142(5):1200–1210. doi:10.1378/chest.11-2614
   PubMed Web of Science ®Google Scholar
• Zhang P, Liu B, Zheng W, et al. Pulmonary microbial composition in sepsis-induced acute respiratory distress syndrome. Front Mol Biosci. 2022;9:862570. doi:10.3389/fmolb.2022.862570
   PubMed Web of Science ®Google Scholar
• Huffnagle GB, Dickson RP, Lukacs NW. The respiratory tract microbiome and lung inflammation: a two-way street. Mucosal Immunol. 2017;10(2):299–306. doi:10.1038/mi.2016.108
   PubMed Web of Science ®Google Scholar
• He Y, Wen Q, Yao F, et al. Gut-lung axis: the microbial contributions and clinical implications. Crit Rev Microbiol. 2017;43(1):81–95. doi:10.1080/1040841X.2016.1176988
   PubMed Web of Science ®Google Scholar
• Pattaroni C, Watzenboeck ML, Schneidegger S, et al. Early-life formation of the microbial and immunological environment of the human airways. Cell Host Microbe. 2018;24(6):857–865. doi:10.1016/j.chom.2018.10.019
   PubMed Web of Science ®Google Scholar
• de Vos WM, Tilg H, Van Hul M, et al. Gut microbiome and health: mechanistic insights. Gut. 2022;71(5):1020–1032. doi:10.1136/gutjnl-2021-326789
   PubMed Web of Science ®Google Scholar
• Ashique S, De Rubis G, Sirohi E, et al. Short Chain Fatty Acids: fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases. Chem Biol Interact. 2022;368:110231. doi:10.1016/j.cbi.2022.110231
   PubMed Web of Science ®Google Scholar
• Pabst O, Hornef MW, Schaap FG, et al. Gut-liver axis: barriers and functional circuits. Nat Rev Gastroenterol Hepatol. 2023;20(7):447–461. doi:10.1038/s41575-023-00771-6
   PubMed Web of Science ®Google Scholar
• Liu M, Nieuwdorp M, de Vos WM, et al. Microbial tryptophan metabolism tunes host immunity, metabolism, and extraintestinal disorders. Metabolites. 2022;12(9):834. doi:10.3390/metabo12090834
   PubMed Web of Science ®Google Scholar
• Rothhammer V, Mascanfroni ID, Bunse L, et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med. 2016;22(6):586–597. doi:10.1038/nm.4106
   PubMed Web of Science ®Google Scholar
• Gao K, Mu CL, Farzi A, et al. Tryptophan metabolism: a link between the gut microbiota and brain. Adv Nutr. 2020;11(3):709–723. doi:10.1093/advances/nmz127
   PubMed Web of Science ®Google Scholar
• Qi Q, Li J, Yu B, et al. Host and gut microbial tryptophan metabolism and type 2 diabetes: an integrative analysis of host genetics, diet, gut microbiome and circulating metabolites in cohort studies. Gut. 2022;71(6):1095–1105. doi:10.1136/gutjnl-2021-324053
   PubMed Web of Science ®Google Scholar
• Liu Y, Pei Z, Pan T, et al. Indole metabolites and colorectal cancer: gut microbial tryptophan metabolism, host gut microbiome biomarkers, and potential intervention mechanisms. Microbiol Res. 2023;272:127392. doi:10.1016/j.micres.2023.127392
   PubMedGoogle Scholar
• Su X, Gao Y, Yang R. Gut microbiota-derived tryptophan metabolites maintain gut and systemic homeostasis. Cells. 2022;11(15):2296. doi:10.3390/cells11152296
   PubMed Web of Science ®Google Scholar
• Major J, Crotta S, Finsterbusch K, et al. Endothelial AHR activity prevents lung barrier disruption in viral infection. Nature. 2023;621(7980):813–820. doi:10.1038/s41586-023-06287-y
   PubMed Web of Science ®Google Scholar
• De Luca D, van Kaam AH, Tingay DG, et al. The Montreux definition of neonatal ARDS: biological and clinical background behind the description of a new entity. Lancet Respir Med. 2017;5(8):657–666. doi:10.1016/S2213-2600(17)30214-X
   PubMed Web of Science ®Google Scholar
• Chen L, Li J, Shi Y. Clinical characteristics and outcomes in neonates with perinatal acute respiratory distress syndrome in China: a national, multicentre, cross-sectional study. EClinicalMedicine. 2023;55:101739. doi:10.1016/j.eclinm.2022.101739
   PubMedGoogle Scholar
• Bruschettini M, Hassan KO, Romantsik O, et al. Interventions for the management of transient tachypnoea of the newborn - an overview of systematic reviews. Cochrane Database Syst Rev. 2022;2:D13563.
   Google Scholar
• Enav H, Backhed F, Ley RE. The developing infant gut microbiome: a strain-level view. Cell Host Microbe. 2022;30(5):627–638. doi:10.1016/j.chom.2022.04.009
   PubMed Web of Science ®Google Scholar
• Sakonidou S, Dhaliwal J. The management of neonatal respiratory distress syndrome in preterm infants (European Consensus Guidelines--2013 update). Arch Dis Child Educ Pract Ed. 2015;100(5):257–259. doi:10.1136/archdischild-2014-306642
   PubMed Web of Science ®Google Scholar
• Alhassen Z, Vali P, Guglani L, et al. Recent advances in pathophysiology and management of transient tachypnea of newborn. J Perinatol. 2021;41(1):6–16. doi:10.1038/s41372-020-0757-3
   PubMed Web of Science ®Google Scholar
• Hooper LV, Macpherson AJ. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol. 2010;10(3):159–169. doi:10.1038/nri2710
   PubMed Web of Science ®Google Scholar
• Cani PD. Human gut microbiome: hopes, threats and promises. Gut. 2018;67(9):1716–1725. doi:10.1136/gutjnl-2018-316723
   PubMed Web of Science ®Google Scholar
• Dickson RP, Erb-Downward JR, Huffnagle GB. Homeostasis and its disruption in the lung microbiome. Am J Physiol Lung Cell Mol Physiol. 2015;309(10):L1047–L1055. doi:10.1152/ajplung.00279.2015
   PubMed Web of Science ®Google Scholar
• Huang YJ, Nariya S, Harris JM, et al. The airway microbiome in patients with severe asthma: associations with disease features and severity. J Allergy Clin Immunol. 2015;136(4):874–884. doi:10.1016/j.jaci.2015.05.044
   PubMed Web of Science ®Google Scholar
• Wang J, Chai J, Zhang L, et al. Microbiota associations with inflammatory pathways in asthma. Clin Exp Allergy. 2022;52(5):697–705. doi:10.1111/cea.14089
   PubMed Web of Science ®Google Scholar
• Bernasconi E, Pattaroni C, Koutsokera A, et al. Airway microbiota determines innate cell inflammatory or tissue remodeling profiles in lung transplantation. Am J Respir Crit Care Med. 2016;194(10):1252–1263. doi:10.1164/rccm.201512-2424OC
   PubMed Web of Science ®Google Scholar
• Dicker AJ, Huang J, Lonergan M, et al. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2021;147(1):158–167. doi:10.1016/j.jaci.2020.02.040
   PubMed Web of Science ®Google Scholar
• Siwicka-Gieroba D, Czarko-Wicha K. Lung microbiome - A modern knowledge. Cent Eur J Immunol. 2020;45(3):342–345. doi:10.5114/ceji.2020.101266
   PubMed Web of Science ®Google Scholar
• Puccetti M, Pariano M, Costantini C, et al. Pharmaceutically active microbial AhR agonists as innovative biodrugs in inflammation. Pharmaceuticals. 2022;15(3):336. doi:10.3390/ph15030336
   Web of Science ®Google Scholar
• Ahlawat S, Asha, Sharma KK. Gut-organ axis: a microbial outreach and networking. Lett Appl Microbiol. 2021;72(6):636–668. doi:10.1111/lam.13333
   PubMed Web of Science ®Google Scholar
• Shen Y, Yu F, Zhang D, et al. Dynamic alterations in the respiratory tract microbiota of patients with COVID-19 and its association with microbiota in the gut. Adv Sci. 2022;9(27):e2200956. doi:10.1002/advs.202200956
   Web of Science ®Google Scholar
• Rigauts C, Aizawa J, Taylor SL, et al. Rothia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease. Eur Respir J. 2022;59(5):2101293. doi:10.1183/13993003.01293-2021
   PubMed Web of Science ®Google Scholar
• Kolling Y, Salva S, Villena J, et al. Non-viable immunobiotic Lactobacillus rhamnosus CRL1505 and its peptidoglycan improve systemic and respiratory innate immune response during recovery of immunocompromised-malnourished mice. Int Immunopharmacol. 2015;25(2):474–484. doi:10.1016/j.intimp.2015.02.006
   PubMed Web of Science ®Google Scholar
• Ksonzekova P, Bystricky P, Vlckova S, et al. Exopolysaccharides of Lactobacillus reuteri: their influence on adherence of E. coli to epithelial cells and inflammatory response. Carbohydr Polym. 2016;141:10–19. doi:10.1016/j.carbpol.2015.12.037
   PubMed Web of Science ®Google Scholar
• Percopo CM, Dyer KD, Garcia-Crespo KE, et al. B cells are not essential for lactobacillus-mediated protection against lethal pneumovirus infection. J Immunol. 2014;192(11):5265–5272. doi:10.4049/jimmunol.1400087
   PubMed Web of Science ®Google Scholar
• Forsythe P, Inman MD, Bienenstock J. Oral treatment with live lactobacillus reuteri inhibits the allergic airway response in mice. Am J Respir Crit Care Med. 2007;175(6):561–569. doi:10.1164/rccm.200606-821OC
   PubMed Web of Science ®Google Scholar
• Carvalho JL, Miranda M, Fialho AK, et al. Oral feeding with probiotic Lactobacillus rhamnosus attenuates cigarette smoke-induced COPD in C57Bl/6 mice: relevance to inflammatory markers in human bronchial epithelial cells. PLoS One. 2020;15(4):e225560. doi:10.1371/journal.pone.0225560
   Web of Science ®Google Scholar
• Bidossi A, De Grandi R, Toscano M, et al. Probiotics Streptococcus salivarius 24SMB and Streptococcus oralis 89a interfere with biofilm formation of pathogens of the upper respiratory tract. BMC Infect Dis. 2018;18(1):653. doi:10.1186/s12879-018-3576-9
   PubMedGoogle Scholar
• Galazzo G, van Best N, Bervoets L, et al. Development of the microbiota and associations with birth mode, diet, and atopic disorders in a longitudinal analysis of stool samples, collected from infancy through early childhood. Gastroenterology. 2020;158(6):1584–1596. doi:10.1053/j.gastro.2020.01.024
   PubMed Web of Science ®Google Scholar
• Backhed F, Roswall J, Peng Y, et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe. 2015;17(5):690–703. doi:10.1016/j.chom.2015.04.004
   PubMed Web of Science ®Google Scholar
• Ratto D, Roda E, Romeo M, et al. The many ages of microbiome-gut-brain axis. Nutrients. 2022;15(1):14. doi:10.3390/nu15010014
   PubMedGoogle Scholar
• Shi H, Nelson JW, Phillips S, et al. Alterations of the gut microbial community structure and function with aging in the spontaneously hypertensive stroke prone rat. Sci Rep. 2022;12(1):8534. doi:10.1038/s41598-022-12578-7
   PubMed Web of Science ®Google Scholar
• Kim B, Wang YC, Hespen CW, et al. Enterococcus faecium secreted antigen A generates muropeptides to enhance host immunity and limit bacterial pathogenesis. Elife. 2019;8:e45343.
   PubMed Web of Science ®Google Scholar
• Lamas B, Richard ML, Leducq V, et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat Med. 2016;22(6):598–605. doi:10.1038/nm.4102
   PubMed Web of Science ®Google Scholar
• Lavelle A, Sokol H. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2020;17(4):223–237. doi:10.1038/s41575-019-0258-z
   PubMed Web of Science ®Google Scholar
• Lamas B, Natividad JM, Sokol H. Aryl hydrocarbon receptor and intestinal immunity. Mucosal Immunol. 2018;11(4):1024–1038. doi:10.1038/s41385-018-0019-2
   PubMed Web of Science ®Google Scholar
• Romani L, Zelante T, De Luca A, et al. Microbiota control of a tryptophan-AhR pathway in disease tolerance to fungi. Eur J Immunol. 2014;44(11):3192–3200. doi:10.1002/eji.201344406
   PubMed Web of Science ®Google Scholar
• Puccetti M, Paolicelli G, Oikonomou V, et al. Towards targeting the aryl hydrocarbon receptor in cystic fibrosis. Mediators Inflamm. 2018;2018:1601486. doi:10.1155/2018/1601486
   PubMed Web of Science ®Google Scholar
• Yan Z, Chen B, Yang Y, et al. Multi-omics analyses of airway host-microbe interactions in chronic obstructive pulmonary disease identify potential therapeutic interventions. Nat Microbiol. 2022;7(9):1361–1375. doi:10.1038/s41564-022-01196-8
   PubMed Web of Science ®Google Scholar
• Ehrlich AM, Pacheco AR, Henrick BM, et al. Indole-3-lactic acid associated with Bifidobacterium-dominated microbiota significantly decreases inflammation in intestinal epithelial cells. BMC Microbiol. 2020;20(1):357. doi:10.1186/s12866-020-02023-y
   PubMed Web of Science ®Google Scholar
• Han JX, Tao ZH, Wang JL, et al. Microbiota-derived tryptophan catabolites mediate the chemopreventive effects of statins on colorectal cancer. Nat Microbiol. 2023;8(5):919–933. doi:10.1038/s41564-023-01363-5
   PubMed Web of Science ®Google Scholar
• Yin J, Zhang Y, Liu X, et al. Gut microbiota-derived indole derivatives alleviate neurodegeneration in aging through activating GPR30/AMPK/SIRT1 pathway. Mol Nutr Food Res. 2023;67(9):e2200739. doi:10.1002/mnfr.202200739
   PubMed Web of Science ®Google Scholar
• Miao H, Wang YN, Yu XY, et al. Lactobacillus species ameliorate membranous nephropathy through inhibiting the aryl hydrocarbon receptor pathway via tryptophan-produced indole metabolites. Br J Pharmacol. 2023;181(1):162–179. doi:10.1111/bph.16219
   PubMed Web of Science ®Google Scholar
• Zou YT, Zhou J, Wu CY, et al. Protective effects of Poria cocos and its components against cisplatin-induced intestinal injury. J Ethnopharmacol. 2021;269:113722. doi:10.1016/j.jep.2020.113722
   PubMed Web of Science ®Google Scholar
• Fan Q, Guan X, Hou Y, et al. Paeoniflorin modulates gut microbial production of indole-3-lactate and epithelial autophagy to alleviate colitis in mice. Phytomedicine. 2020;79:153345. doi:10.1016/j.phymed.2020.153345
   PubMed Web of Science ®Google Scholar
• Sulo G, Vollset SE, Nygard O, et al. Neopterin and kynurenine-tryptophan ratio as predictors of coronary events in older adults, the Hordaland Health Study. Int J Cardiol. 2013;168(2):1435–1440. doi:10.1016/j.ijcard.2012.12.090
   PubMed Web of Science ®Google Scholar
• Zuo H, Ueland PM, Ulvik A, et al. Plasma biomarkers of inflammation, the kynurenine pathway, and risks of all-cause, cancer, and cardiovascular disease mortality: the hordaland health study. Am J Epidemiol. 2016;183(4):249–258. doi:10.1093/aje/kwv242
   PubMed Web of Science ®Google Scholar
• Sorgdrager F, Naude P, Kema IP, et al. Tryptophan metabolism in inflammaging: from biomarker to therapeutic target. Front Immunol. 2019;10:2565. doi:10.3389/fimmu.2019.02565
   PubMed Web of Science ®Google Scholar
• Dang G, Wen X, Zhong R, et al. Pectin modulates intestinal immunity in a pig model via regulating the gut microbiota-derived tryptophan metabolite-AhR-IL22 pathway. J Anim Sci Biotechnol. 2023;14(1):38. doi:10.1186/s40104-023-00838-z
   PubMed Web of Science ®Google Scholar
• Venkatesh M, Mukherjee S, Wang H, et al. Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4. Immunity. 2014;41(2):296–310. doi:10.1016/j.immuni.2014.06.014
   PubMed Web of Science ®Google Scholar
• Cervantes-Barragan L, Chai JN, Tianero MD, et al. Lactobacillus reuteri induces gut intraepithelial CD4(+)CD8alphaalpha(+) T cells. Science. 2017;357(6353):806–810. doi:10.1126/science.aah5825
   PubMed Web of Science ®Google Scholar
• Gutierrez-Vazquez C, Quintana FJ. Regulation of the immune response by the aryl hydrocarbon receptor. Immunity. 2018;48(1):19–33. doi:10.1016/j.immuni.2017.12.012
   PubMed Web of Science ®Google Scholar